An integrated metabolomic and proteomic approach for the identification of covalent inhibitors of the main protease (Mpro) of SARS-COV-2 from crude natural extracts-Reference-Cited by-同舟云学术

An integrated metabolomic and proteomic approach for the identification of covalent inhibitors of the main protease (Mpro) of SARS-COV-2 from crude natural extracts

Published:2023-01 Issue: Volume:252 Page:123824
ISSN:0039-9140
Container-title:Talanta
language:en
Short-container-title:Talanta

Author:

Baron Giovanna^ORCID,Borella Sofia^ORCID,della Vedova Larissa^ORCID,Vittorio Serena^ORCID,Vistoli Giulio,Carini Marina,Aldini Giancarlo,Altomare Alessandra^ORCID

Funder

Regione Lombardia

Publisher

Elsevier BV

Subject

Analytical Chemistry

Reference50 articles.

1. Treating COVID-19-off-label drug use, compassionate use, and randomized clinical trials during pandemics;Kalil;JAMA,2020

2. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review;Sanders;JAMA,2020

3. Drugs targeting various stages of the SARS-CoV-2 life cycle: exploring promising drugs for the treatment of Covid-19;Poduri;Cell. Signal.,2020

4. Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?;Batlle;Clin. Sci. (Lond.),2020

5. Coronavirus biology and replication: implications for SARS-CoV-2;V'kovski;Nat. Rev. Microbiol.,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibitors of SARS-CoV-2 Main Protease (Mpro) as Anti-Coronavirus Agents;Biomolecules;2024-07-04

2. Screening of Mpro Protease (SARS-CoV-2) Covalent Inhibitors from an Anthocyanin-Rich Blueberry Extract Using an HRMS-Based Analytical Platform;Molecules;2024-06-06

3. Discovery of a septin-4 covalent binder with antimetastatic activity in a mouse model of melanoma;Bioorganic Chemistry;2024-03

4. The potential of PCNA inhibition as a therapeutic strategy in cervical cancer;Journal of Medical Virology;2023-11

5. Discovery of the covalent SARS‐CoV‐2 M^pro inhibitors from antiviral herbs via integrating target‐based high‐throughput screening and chemoproteomic approaches;Journal of Medical Virology;2023-11